Moreover, knockdown of SLC39A6 expression modulated the malignant phenotype of ESCC cells, resulting in significantly reduced proliferation and invasion with MET phenotype in vitro. This evidence concerns the gene SLC39A6 and esophageal squamous cell carcinoma.